NCT06554795
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06554795
Title First-in-human Study of DB-1419 for Advanced/Metastatic Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors DualityBio Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | AUS

Facility Status City State Zip Country Details
Site USA08-0 NOT_YET_RECRUITING Newport Beach California 92663 United States Details
Site USA06-0 NOT_YET_RECRUITING Washington D.C. District of Columbia 20007 United States Details
Site USA02 NOT_YET_RECRUITING Florida City Florida 32827 United States Details
Site USA04-0 NOT_YET_RECRUITING Edison New Jersey 08837 United States Details
Site USA03 NOT_YET_RECRUITING Carolina North Carolina 28078 United States Details
Site USA05-0 NOT_YET_RECRUITING Philadelphia Pennsylvania 19107 United States Details
Site USA07-0 NOT_YET_RECRUITING Nashville Tennessee 37203 United States Details
AUS03-0 NOT_YET_RECRUITING North Ryde New South Wales 2109 Australia Details
AUS01-0 NOT_YET_RECRUITING Randwick New South Wales 2031 Australia Details
AUS02-0 RECRUITING Nedlands Western Australia 6009 Australia Details
Site CHN08-0 NOT_YET_RECRUITING Harbin Heilongjiang 150001 China Details
Site CHN03-0 NOT_YET_RECRUITING Luoyang Henan 471000 China Details
Site CHN06-0 NOT_YET_RECRUITING Shanghai Shanghai Municipality 200030 China Details
Site CHN13-0 NOT_YET_RECRUITING Changchun China Details
Site CHN01-0 NOT_YET_RECRUITING Shanghai China Details
Site CHN05-0 NOT_YET_RECRUITING Shanghai China Details
Site CHN09-0 NOT_YET_RECRUITING Zhengzhou China Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field